Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statin-associated neuromyotoxicity.

Steven K Baker1, Mark A Tarnopolsky

  • 1Department of Pediatrics, McMaster University Medical Center, Hamilton, Ontario, Canada.

Drugs of Today (Barcelona, Spain : 1998)
|July 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of baclofen and lorazepam on interhemispheric inhibition in humans.

Experimental physiology·2026
Same author

Direct AMPK Activation Confers Mutation-Independent Therapeutic Benefit in Duchenne Muscular Dystrophy.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Muscle mitochondrial changes in antisynthetase syndrome and other idiopathic inflammatory myopathies.

Journal of neuropathology and experimental neurology·2025
Same author

Impact of high-intensity interval training on cardiometabolic health in patients with diabesity: a systematic review and meta-analysis of randomized controlled trials.

Diabetology & metabolic syndrome·2025
Same author

A Multi-Ingredient Supplement Improves Body Re-Composition, Ovarian Aging Markers, and Reproductive Success in Young and Middle-Aged Female Mice.

Biomolecules·2025
Same author

Multi-ingredient supplementation for combating sarcopenia and polymorbidity.

Current opinion in clinical nutrition and metabolic care·2025
Same journal

Monoclonal antibodies for treatment of osteoporosis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Sugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Mitapivat for sickle cell disease and thalassemia.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Cenegermin for the treatment of dry eye disease.

Drugs of today (Barcelona, Spain : 1998)·2023
See all related articles

Statins effectively reduce cardiovascular disease but can cause muscle and nerve toxicity. While statin-induced myopathy is usually reversible, neuropathy may be less so, with disrupted mevalonate metabolism a potential cause.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Neurology

Background:

  • Cardiovascular diseases are a leading cause of death, with statins widely used to manage atherosclerosis.
  • Statin therapy can lead to muscle (myopathy) and nerve (neuropathy) toxicity, sometimes causing treatment cessation.
  • While statin myopathy is typically reversible, the natural history and reversibility of statin-associated sensorimotor neuropathy are less understood.

Purpose of the Study:

  • To explore the potential causes and pathophysiology of statin-induced neuromyotoxicity.
  • To highlight the role of disrupted mevalonate metabolism in statin-related adverse effects.
  • To discuss the implications of impaired isoprenoid biosynthesis on cellular functions.

Main Methods:

  • Review of existing literature on statin toxicity.

Related Experiment Videos

  • Discussion of biochemical pathways affected by statin use, focusing on mevalonate metabolism.
  • Analysis of cellular consequences of disrupted isoprenoid biosynthesis.

    • Main Results:

    • Statin-induced myopathy, characterized by muscle pain and elevated creatine kinase, is generally reversible upon drug withdrawal.
    • Sensorimotor neuropathy appears less reversible, particularly when large fiber function is clinically affected.
    • Disrupted mevalonate metabolism can impair the synthesis of crucial isoprenoids (e.g., coenzyme Q10, dolichols), affecting various cellular processes.

    Conclusions:

    • The pathophysiology of statin neuromyotoxicity is complex and not fully elucidated.
    • Understanding the cellular effects of deranged isoprenoid metabolism may provide insights into statin-induced nerve and muscle damage.
    • Further research into these biochemical pathways is warranted to better comprehend and potentially mitigate statin toxicity.